The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
With that comes smaller margins in the future/bigger liability to Lilly.
Not sure they are the charitable type.
Need minimum of what £25m to through year?
What’s the maximum Hemo could get out of a placing? PR machine cranking up (slightly). Is there one in pipeline to cancel CLN’s. Then you would assume Vlad would have to secure other funding.
Star, I truly find genuine PI’s losing money disgusting whilst others bathe in champagne. The pre Christmas pump was unacceptable. We all know the rules and risks but it take time to understand the market. This is main market and not even AIM!!!
I feel Covid arrived at the right time,
I for one will be asking Vlad how many lives HEMO has saved.
I won’t be pressured into the Channel 5 style, oh it’s charity advert.
Vlad needs to deliver. As a CEO he is shocking. However in his words he is the best man for the job..wonder why if he has cost shareholders 14% of £12m (give or take 1% or £1m for a smart arse)
Here’s a question to almost all on this board. Bearing in mind the threats on ADVFN for legal action, can any of you give me an example of corporate forward statements since 2017,
which are true and on time and will have a meterial effect on SP and give you the belief to invest?
Bill, as stated there are a few on here who have taken PI’s on a ride.
The Billionaire is out to make money. He isn’t a friend of PI’s or Vlad.
Next 12months will depend on a corporate sponsor not on a product. Obviously there will a pump (very soon, probably CBR) and maybe an old associate helping Vlad out. HEMO can’t afford to pay off
CLN unless someone like Caplan comes forward. Inflection 2022, if still liquid (thus my shock at Vlads payrise for achieving nothing commercial). I don’t
Wish the majority bad luck. However those who tried to fleece everyone need to be held to account.
Sub 4 all year? Maybe a pump will take it beyond short term.
Remember Vlads elation and arrogance of 8p over 5 years..
OnedollarBill, ORPHY and HH all in denial and under the cult influence.
It’s like his PR, cheapest is best. Indications that a small Turkish outfit are running it.
Ssccss. Spot on. You might never agree with me, but in this instance I totally agree with you.
A financial instrument used for poor credit with high worth investors getting a great rate of return.
Maybe if CLN’s are cancelled, Vlad would like to work 3-4 years without a salary to cover the cost, otherwise it’s the shareholders paying #lifestyle
A huge cost to the business to cancel the CLN’s. Whose gonna pay for that?!
About time that Canadian Billionaire stepped in.. ...
Thevid I know many on this forum don’t know how to research, if you need advice about searching posting history I am happy to give you tutorial.
In the meantime, spot on again... lol 10p wasn’t spot on!
If you care to look back fully at my LSE posting history, I took a position on 29th at 68.50. Yes I had atop up at 1.30 but purchased majority around the 70 level.
Fully documented on LSE.
In GDR sub 70
Death spiral finance. Crazy to get involved.
Hope this doesn’t go sub 52 week low.
Whose paying for the increase in salary.
Executive Directors Dr Vladislav Sandler Total
Basic salary 2020
£’000
200
Basic salary 2019
£’000
145
Pension Total 2020 £’000 2020
5
Pension 2019 £’000
4
£’000
205
Total 2019 £’000
149
LSE if you want to check the above data go to :
https://hemogenyx.com/wp-content/uploads/2020/12/Hemogenyx-Pharmaceuticals-plc-2020-Annual-Report.pdf
Why the Y-O-Y increase?
And why do LSE remove a post stating FACTS which appear in Annual Accounts?
LSE admin, your opportunity to reply?
It must be positive that Vlad has taken a huge increase in salary. Whose paying for that.